Holen Sie sich die Stockscreener-App
19.66
3.10%
-0.63
Handel nachbörslich:
19.66
Schlusskurs vom Vortag:
$20.29
Offen:
$20.36
24-Stunden-Volumen:
304.65K
Relative Volume:
0.66
Marktkapitalisierung:
$567.77M
Einnahmen:
$290.71M
Nettoeinkommen (Verlust:
$-163.43M
KGV:
-3.5876
EPS:
-5.48
Netto-Cashflow:
$11.70M
1W Leistung:
+5.42%
1M Leistung:
+3.75%
6M Leistung:
+10.51%
1J Leistung:
-11.92%
1-Tages-Spanne:
$19.43
$20.55
1-Wochen-Bereich:
$18.51
$20.55
52-Wochen-Spanne:
$14.76
$25.11
Fulgent Genetics Inc Stock (FLGT) Company Profile
Firmenname
Fulgent Genetics Inc
Sektor
Branche
Telefon
626-350-0537
Adresse
4399 SANTA ANITA AVE, EL MONTE
Vergleichen Sie FLGT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FLGT
Fulgent Genetics Inc
|
19.66 | 567.77M | 290.71M | -163.43M | 11.70M | -5.48 |
|
TMO
Thermo Fisher Scientific Inc
|
406.05 | 153.96B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
187.82 | 138.19B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
509.42 | 39.13B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
111.52 | 30.65B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
141.82 | 26.52B | 15.50B | 1.33B | 2.16B | 7.34 |
Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-12-07 | Eingeleitet | UBS | Neutral |
| 2022-12-08 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-11-18 | Eingeleitet | Raymond James | Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-02-04 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Underperform |
| 2021-01-08 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2020-11-24 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-08-20 | Eingeleitet | Oppenheimer | Outperform |
| 2020-05-29 | Eingeleitet | BTIG Research | Buy |
| 2019-11-05 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-03-01 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-11-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
Alle ansehen
Fulgent Genetics Inc Aktie (FLGT) Neueste Nachrichten
Bridgeway Capital Management LLC Sells 20,391 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Fulgent Genetics, Inc. (NASDAQ:FLGT) Shares Sold by Dimensional Fund Advisors LP - MarketBeat
Caxton Associates LP Acquires 28,502 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Shares Gap DownWhat's Next? - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Receives Outperform Rating from Raymond James - MarketBeat
Here's Why It's Unlikely That Fulgent Genetics, Inc.'s (NASDAQ:FLGT) CEO Will See A Pay Rise This Year - simplywall.st
Fulgent Genetics rises on earnings, revenue beat - MSN
Fulgent Genetics (NASDAQ:FLGT) Shares Gap Up After Better-Than-Expected Earnings - MarketBeat
Almitas Capital LLC Acquires New Shares in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Updates FY 2025 Earnings Guidance - MarketBeat
Fulgent Genetics (FLGT) Sees Price Target Raised by Piper Sandle - GuruFocus
Fulgent Genetics (FLGT) Price Target Boosted by Piper Sandler | - GuruFocus
Fulgent Genetics (FLGT) Sees Price Target Raised by Piper Sandler | FLGT Stock News - GuruFocus
Fulgent Genetics’ (FLGT) “Outperform” Rating Reaffirmed at Raymond James - Defense World
Fulgent Genetics (FLGT) Target Price Raised by Raymond James | F - GuruFocus
Fulgent Genetics (FLGT) Target Price Raised by Raymond James | FLGT Stock News - GuruFocus
Fulgent Genetics (FLGT) Sees Increased Price Target Following St - GuruFocus
Fulgent Genetics (NASDAQ:FLGT) Announces Quarterly Earnings Results - MarketBeat
Fulgent Genetics (FLGT) Sees Increased Price Target Following Strong Q1 Performance | FLGT Stock News - GuruFocus
Fulgent revenue up 16% to USD 73.5M in Q1 2025 - Medical Buyer
Is Fulgent Genetics (NASDAQ:FLGT) Using Too Much Debt? - simplywall.st
Park West Asset Management LLC Cuts Stock Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Renaissance Technologies LLC Reduces Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Nebula Research & Development LLC Takes Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2025 Earnings Call Transcript - Insider Monkey
Fulgent Genetics Inc (FLGT) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges - Yahoo Finance
Fulgent Genetics Inc (FLGT) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges By GuruFocus - Investing.com Canada
Fulgent Genetics Reports Strong Q1 2025 Growth - TipRanks
Fulgent Genetics earnings beat by $0.12, revenue fell short of estimates - Investing.com Canada
Fulgent Genetics Q1 2025 Earnings: Revenue Surpasses Estimates a - GuruFocus
Fulgent Genetics (FLGT) Q1 Earnings Surpass Expectations - GuruFocus
Fulgent Genetics (FLGT) Stock Surges After Strong Q1 Results - GuruFocus
Earnings call transcript: Fulgent Genetics Q1 2025 beats EPS forecast, stock rises - Investing.com India
Press Release Distribution & PR Platform - ACCESS Newswire
Fulgent Genetics Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Fulgent Genetics, Inc. Reiterates Earnings Guidance for the Fiscal Year 2025 - marketscreener.com
Fulgent Genetics, Inc. (FLGT) Q1 Earnings and Revenues Beat Estimates - Yahoo Finance
FLGT Reiterates 2025 Revenue Outlook Amid Strong Start | FLGT St - GuruFocus
Fulgent Reports First Quarter 2025 Financial Results | FLGT Stoc - GuruFocus
Fulgent Reports First Quarter 2025 Financial Results - BioSpace
A significant driver of top-line growth: Fulgent Genetics Inc (FLGT) - Sete News
Fulgent Genetics Reports Strong Q1 2025 Financial Results - TipRanks
FLGT Reiterates 2025 Revenue Outlook Amid Strong Start | FLGT Stock News - GuruFocus
Fulgent Genetics, Inc. SEC 10-Q Report - TradingView
Fulgent Reports First Quarter 2025 Financial Results | FLGT Stock News - GuruFocus
Investor Network: Fulgent Genetics, Inc. to Host Earnings Call - ACCESS Newswire
A Peek at Fulgent Genetics's Future Earnings - Nasdaq
Fulgent Genetics Inc [FLGT] Shares Fall Approximately -13.68% Over the Year - knoxdaily.com
Finanzdaten der Fulgent Genetics Inc-Aktie (FLGT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):